β-Lactamase-IN-2 (Synonyms: EX-A4764; UUN51204) |
| Katalog-Nr.GC62235 |
β-Lactamase-IN-2 ist ein Beta-Lactamase-Inhibitor, extrahiert aus dem Patent WO 2019075084 A1, Verbindung 1.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2114651-20-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
β-Lactamase-IN-2 is a beta-lactamase inhibitor, extracted from patent WO 2019075084 A1, compound 1. β-Lactamase-IN-2 has anti-microbial and anti-bacterial effects[1].
[1]. Scott J. Hecker, et al. Boronic acid derivatives and synthesis thereof. Patent WO 2019075084
Review for β-Lactamase-IN-2
Average Rating: 5 (Based on Reviews and 35 reference(s) in Google Scholar.)
Review for β-Lactamase-IN-2
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *